Plasma P-tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant cerebrovascular disease.
Joyce R ChongNicholas J AshtonThomas K KarikariTomotaka TanakaFrancis N SaridinAnthonin ReilhacEdward G RobinsYing-Hwey NaiHenri VroomanSaima HilalHenrik ZetterbergKaj BlennowMitchell Kim Peng LaiChristopher P ChenPublished in: Alzheimer's & dementia : the journal of the Alzheimer's Association (2021)
Plasma P-tau181/Aβ42 ratio may be a noninvasive means of identifying AD with elevated brain amyloid in populations with concomitant CeVD.